AIM To evaluate the role of intestinal microflora and early formula feeding in the maturation of humoral immunity in healthy newborn infants.
STUDY DESIGN Sixty four healthy infants were studied. Faecal colonisation withBacteroides fragilis group,Bifidobacterium-like, andLactobacillus-like bacteria was examined at 1, 2, and 6 months of age, and also the number of IgA-secreting, IgM-secreting, and IgG-secreting cells (detected by ELISPOT) at 0, 2, and 6 months of age.
RESULTS Intestinal colonisation with bacteria from the B fragilis group was more closely associated with maturation of IgA-secreting and IgM-secreting cells than colonisation with the other bacterial genera studied or diet. Infants colonised withB fragilis at 1 month of age had more IgA-secreting and IgM-secreting cells/106 mononuclear cells at 2 months of age (geometric mean (95% confidence interval) 1393 (962 to 2018) and 754 (427 to 1332) respectively) than infants not colonised (1015 (826 to 1247) and 394 (304 to 511) respectively); p = 0.04 and p = 0.009 respectively.
CONCLUSIONS The type of bacteria colonising the intestine of newborns and the timing may determine the immunomodulation of the naive immune system.
- intestinal colonisation
- immune system
- immunoglobulin secreting cell
- humoral immunity
- delivery method
Statistics from Altmetric.com
- intestinal colonisation
- immune system
- immunoglobulin secreting cell
- humoral immunity
- delivery method
From the first moments after birth, the gastrointestinal tract is constantly challenged by a myriad of bacterial and food antigens. More than 70% of all immune cells in the human body are located in the intestine to combat this challenge.1 Therefore there is important immunological protection in the milieu where most new antigens are encountered.2 This immunological protection, primarily composed of locally produced secretory IgA, is quantitatively and functionally defective for a variable period after birth.3 The number of IgA plasma cells in the duodenal mucosa reaches that of adults by 2 years of age, whereas the level of mucosal secretory IgA antibodies reaches adult levels only at the age of 6–8 years.4 ,5 It has been postulated that undeveloped mucosal immunological protection is the reason for the higher vulnerability to infection and the more prevalent sensitisation to dietary antigens seen in early infancy.3
Considering that the mucosal surfaces harbour more bacterial cells than the total number of cells found in the human body, surprisingly little is known about the role of early bacterial colonisation in the development of the immune system in man. The involvement of intestinal colonisation in the fine tuning and maturation of immune responses is well characterised in animal models: both the gut associated immune system and systemic immunity mature on stimulation by the intestinal microflora.1 ,6-8 Furthermore, the timing of the intestinal microbial stimulus seems to be important: neonatal germ-free mice can be made tolerant to food antigens only if the intestinal flora is in place during the neonatal period, whereas later reconstitution fails to allow oral tolerance to be induced.9 Studies in humans have focused only on the effects of intestinal colonisation on specific humoral immunity against the colonising bacteria,10-12 and no data exist on the relation between early intestinal colonisation and maturation of spontaneous overall humoral immunity.
Although the interrelationship between environmental determinants and development of the immune system in humans remains obscure, an increasing number of newborns are exposed to factors that delay intestinal colonisation. These factors include premature birth, delivery by caesarean section, and treatment with antimicrobials.13-16 These factors, along with the “over-hygienic” nature of western society, may deprive infants of an important antigenic stimulus offered by the intestinal flora.17
In an attempt to understand the association between microbial colonisation of the intestine and development of non-specific humoral immunity in man, we studied the faecal flora and number of IgA-secreting, IgG-secreting, and IgM-secreting cells in 64 healthy infants.
SUBJECTS AND STUDY DESIGN
The study group consisted of 64 healthy full term newborns of healthy mothers delivered at the Department of Obstetrics and Gynecology, University Central Hospital, Turku, Finland. Infants were enrolled after written informed consent had been obtained from their parents. Thirty four infants were delivered vaginally and 30 by elective caesarean section because of disproportion or malpresentation. The mothers delivering by caesarean section received 2 g ampicillin intravenously two hours before delivery for selective intrapartum chemoprophylaxis. None of the mothers had received antimicrobial agents in the month before delivery. After delivery, the newborns were admitted randomly to one of the two maternity wards for healthy newborn infants. The study was approved by the joint commission on ethics of Turku University and Turku University Central Hospital.
The mothers kept a diary for the first two months of the infant's life on nutrient intake (breast feeding/quality and volume of formula feeding), any antimicrobial treatment, frequency of normal/colicky crying,18 and the quality and number of stools and vomiting. Further information on feeding, health, growth, and antimicrobial treatment between the ages of 2 and 6 months was collected at a scheduled visit at 6 months of age. The children were clinically examined at the ages of 2 and 6 months, always by the same investigator (MMG). Eleven of the study infants received antimicrobial treatment for upper respiratory tract infection between the ages of 2 and 6 months. These infants were excluded from the study at 6 months of age.
Detailed data on the bacterial culture methods used are presented elsewhere.19 Briefly, faecal bacteria were examined at the ages of 3–5 days, 10 days, and 1, 2, and 6 months by plating on several selective and non-selective culture media. Quantitative counts were obtained for the following bacterial groups: total, aerobic enteric, Bifidobacterium-like,Bacteroides fragilis group (B fragilis), Clostridium perfringens, and Lactobacillus-like. Bacterial counts were expressed as log10 colony-forming units (CFUs) per g wet weight of faeces. Faecal colonisation for a particular bacterial group was considered positive if the bacteria could be detected in the faeces.
IMMUNOGLOBULIN-SECRETING CELLS (ISCS)
An umbilical cord blood sample (mixed blood) and peripheral venous blood samples at the ages of 2 and 6 months were collected for analysis. A 1–5 ml sample of blood was taken into a 5 ml EDTA tube. The numbers of circulating antigen-non-specific IgA-secreting, IgG-secreting, and IgM-secreting cells (ISCs) were measured by the enzyme linked immunospot method (ELISPOT), an enzyme linked immunosorbent assay (ELISA) plaque method,20 ,21 as described previously.22 The total number of IgA-secreting, IgG-secreting, and IgM-secreting cells was calculated to assess the total number of ISCs.
EFFECT OF INTESTINAL MICROFLORA AND TYPE OF FEEDING ON THE NUMBER OF ISCS
The faecal colonisation results for B fragilis, Bifidobacterium-like, andLactobacillus-like bacteria at 1 and 2 months of age were used in this study to divide the infants into colonised and non-colonised subgroups. We chose to compare the faecal colonisation results at 1 month of age (colonised/non-colonised) with the number of ISCs at 2 months of age, and the colonisation results at 2 months of age with the number of ISCs at 6 months of age. This was because it has been shown that mucosal immunity reaches its highest level four to six weeks after artificial colonisation withEscherichia coli in newborn infants12 and that prolonged exposure to antigens in the intestine induces a prolonged response of ISCs.23Furthermore, the diet at this age is composed mostly of milk,24 and the association between diet and ISCs could thus be detected by comparing the form of milk received by the infants. Infants were divided into two feeding groups according to their diet at 2 months of age: exclusively breast fed and partly or totally formula fed.
Secondly, to investigate whether the duration of colonisation is important for the development of ISCs, the colonisation time forB fragilis was used to divide the infants into four different colonisation groups (colonised before 1 month of age, colonised at 1–2 months of age, colonised at 2–6 months of age, and not colonised during the study period). The number of ISCs at 2 and 6 months of age was then compared among these four colonisation groups. Some infants had fluctuating B fragiliscolonisation during the study period—for example, positive at 1 month, negative at 2 months, positive at 6 months; or negative at 1 month, positive at 2 months, negative at 6 months; or positive at 1 month and 2 months, negative at 6 months; or positive at 1 month and negative at 2 and 6 months. The results for these infants were omitted from the analysis.
The Mann-Whitney U test was used to test the difference in bacterial counts, and Fisher's exact test to test the difference in bacterial colonisation rates between the feeding groups. Friedman's test was used to analyse the time effect on ISCs, and Wilcoxon signed rank sum test to test the differences between specific time periods. To analyse simultaneously the effect of bacterial colonisation and diet on the number of ISCs, two way analysis of variance was used after logarithmic (log10) transformation of the ISC data. When the number of ISCs was compared between the groups of infants colonised with B fragilis at different time points, one way analysis of variance was used after logarithmic transformation of the ISC data. Spearman's rank correlation coefficient was used to correlate faecal bacterial counts with the number of ISCs. Bacterial counts are expressed as the median with range or interquartile range (IQR), and ISC results as the geometric mean with 95% confidence intervals (95% CI).
CLINICAL DATA OF STUDY INFANTS
The mean gestational age of the study infants was 39 weeks (range 37–42), the mean birth weight was 3575 g (range 2640–4480), and the median Apgar scores at 1, 5, and 15 minutes were 9 (3–10), 9 (7–10), and 9 (8–10). The number of exclusively breast fed infants at 2 months of age was 41 (64%), 15 infants were partially formula fed (23%) and six exclusively formula fed (9%), and in two cases (3%) information on the type of feeding was missing.
ESTABLISHMENT OF FAECAL MICROFLORA
Table 1 shows the colonisation rates (%) and counts (CFUs/g wet weight of faeces) of bacteria studied (total, aerobic enteric,B fragilis,Bifidobacterium-like,Lactobacillus-like bacteria, andCl perfringens).
The type of feeding was shown to affect the counts ofB fragilis and the colonisation rate ofLactobacillus-like bacteria. Infants who received formula feeds before 2 months of age had higher median counts of B fragilis at 1 and 6 months of age than those exclusively breast fed over 2 months. The median (IQR) counts ofB fragilis at 1 month of age were 10.3 (9.4–10.4) CFUs/g in formula fed infants and 9.0 (8.5–9.6) CFUs/g in breast fed infants (p = 0.02), and at 6 months of age 10.4 (9.3–11.0) and 9.0 (8.0–9.5) CFUs/g respectively (p = 0.01). In addition, a higher proportion of formula fed infants were colonised with Lactobacillus-like bacteria at 3 days of age than exclusively breast fed infants (72%v 44% respectively; p = 0.04) and tended to have a higher colonisation rate at 10 days of age (85%v 57% respectively; p = 0.05).
ONTOGENY OF ISCS
Most of the study infants already had detectable IgG-secreting and IgM-secreting cells in the cord blood, whereas only a few had detectable IgA-secreting cells. The number of ISCs increased significantly with age (p < 0.001) (fig 1A–D). A major increase in all immunoglobulin isotypes had occurred by the age of 2 months (p<0.001), and a further rise was observed between the ages of 2 and 6 months in the IgG isotype (p < 0.001) (fig 1B), but less profoundly in the IgA (p = 0.07) and IgM isotypes (p = 0.14) (fig1A,C).
ASSOCIATION BETWEEN INTESTINAL ANTIGEN STIMULATION AND THE NUMBER OF ISCS
Intestinal antigen stimulation at 1 month of age v number of ISCs at 2 months of age
Colonisation with bacteria of the B fragilis group was most clearly associated with the development of ISCs, compared with the other bacteria studied or the effect of diet. Infants colonised with B fragilis at 1 month of age had more ISCs at 2 months of age than non-colonised infants (fig 2). Two way analysis of variance showed this association to be statistically significant. Infants colonised withB fragilis had more IgA-secreting cells than non-colonised infants (p = 0.04) (table 2). Further, early formula feeding (before 2 months of age) also tended to increase the number of IgA-secreting cells at 2 months of age (p = 0.06) (table 2). Both colonisation with B fragilis and early formula feeding increased, in a parallel way, the number of IgM-secreting cells (p = 0.009 for bacterial colonisation and p = 0.05 for formula feeding) and the total number of ISCs (p = 0.01 for bacterial colonisation and p = 0.02 for formula feeding) at 2 months of age (table 2). The number of IgG-secreting cells was not associated with B fragiliscolonisation at 1 month of age or with early formula feeding (p = 0.12 and p = 0.15 respectively) (table2).
Colonisation with Lactobacillus-like bacteria and Bifidobacterium-like bacteria at 1 month of age was not associated with the number of ISCs at 2 months of age (data not shown).
Intestinal antigen stimulation at 2 months of age v number of ISCs at 6 months of age
A further association was found between B fragilis colonisation at 2 months of age and the number of IgM-secreting cells at 6 months of age. Infants colonised withB fragilis at 2 months of age tended to have more IgM-secreting cells at 6 months of age than non-colonised infants (geometric mean (95% CI) 1029 (691 to 1533) and 622 (447 to 868) IgM-secreting cells/106 mononuclear cells respectively; p = 0.06). Early formula feeding was not further associated with the number of IgM-secreting cells at 6 months of age (p = 0.83).
There was no association between colonisation byLactobacillus-like andBifidobacterium-like bacteria at 2 months of age and the number of ISCs at 6 months of age.
Correlation between number of intestinal bacteria and number of ISCs
A positive correlation was observed between the faecal counts ofB fragilis andBifidobacterium-like bacteria and the number of ISCs: the higher the faecal count of B fragilis at 1 month of age, the higher the number of IgA-secreting and IgM-secreting cells at 2 months of age (ρ = 0.27, p = 0.05 and ρ = 0.29, p = 0.03 respectively). In addition, the faecal count of Bifidobacterium-like bacteria at 1 month of age and the number of IgM-secreting cells at 2 months of age correlated positively (ρ = 0.36, p = 0.006), whereas the faecal counts ofLactobacillus-like bacteria did not correlate with the number of ISCs at any time point.
Association between the time of colonisation and the number of ISCs
In order to study whether the duration of colonisation is important for the development of ISCs, the timing ofB fragilis colonisation was used to divide the infants into four groups: colonised before 1 month of age, colonised at 1–2 months of age, colonised at 2–6 months of age, and not colonised during the study period.
The number of IgA-secreting cells at 2 months of age and IgM-secreting cells at 6 months of age differed between the colonisation groups (table 3). In both cases, the highest numbers of ISCs were found in infants colonised at 1–2 months of age and the lowest numbers in those not colonised. In the case of IgA-secreting cells at 2 months of age, the second highest counts were found in infants colonised at 1 month of age, and for IgM-secreting cells at 6 months of age, in infants colonised at 2–6 months of age. Even though the numbers of IgM-secreting cells at 2 months of age and IgA-secreting cells at 6 months of age did not differ statistically between the colonisation groups, the kinetics of colonisation were very similar for both of these immunoglobulin classes to those for IgA-secreting cells at 2 months and IgM-secreting cells at 6 months of age (table 3). No effect of the timing of colonisation with B fragilis could be found on the number of IgG-secreting cells at 2 and 6 months of age (data not shown).
The role of early exposure to food antigens in the immunomodulation of the naive immune system has been extensively investigated. Whether this exposure leads to sensitisation or development of oral tolerance remains elusive.3 ,25-27What has not been established is the involvement of the massive bacterial antigenic challenge by normal intestinal flora in the maturation of overall humoral immunity in humans.3 ,17
In an attempt to clarify this, we studied faecal colonisation byB fragilis andBifidobacterium-like andLactobacillus-like bacteria using classic bacterial culture methods, and compared the colonisation results with the number of ISCs in the peripheral blood, measured by the ELISPOT method in infants aged 2–6 months. It is clear that intestinal microflora is an extremely complex microenvironment to study.28 Therefore, to investigate host-microbe interactions in man, we chose indicators of the predominant species of intestinal microflora in infants29 ,30.
Intestinal colonisation with B fragilis was associated with elevated numbers of IgA-secreting and IgM-secreting cells in the peripheral blood. This association was consistent at different ages and more clearly observed than that of the other bacterial genera studied or early formula feeding. To our knowledge, this is the first report of an association betweenBacteroides sp and maturation of humoral immunity in humans, and it provides a fresh view of the role of these predominant bacteria of the human gut. To date, most research in this field has concentrated on the immunostimulating properties of lactic acid bacteria,31 and Bacteroidessp have been regarded mainly as opportunistic pathogens.32
Our results agree with experimental studies showing that bacteria of the genus Bacteroides have stronger immunogenic potential for IgA plasma cells of the duodenal lamina propria than several other strains of intestinal microflora,33 and they liberate low molecular mass peptides with immunotriggering activity.34 Our results indicate that these observations may also apply to theBacteroides sp bacteria of the intestinal microflora in humans. Further, our results are consistent with observations from murine studies showing that bacteria of the normal flora induce the immune system much more effectively than food antigens.35
Experimental studies have shown that maternal breast milk IgA can forestall the production of natural IgA in gut associated lymphoid tissue of the offspring.36 This could explain the lower number of ISCs in the breast fed infants compared with the formula fed infants in our study. The type of feeding may influence maturation of the immune system on two levels. Firstly, breast milk affects the colonisation process of young infants; in the present study breast fed infants had lower faecal counts of B fragilis at 1 and 6 months of age than formula fed infants. Secondly, a trend towards positive interaction between type of feeding and B fragilis colonisation was shown in the number of IgA-secreting cells and the total number of ISCs when analysed by two way analysis of variance (table 2). This indicates that the association between intestinal B fragilis colonisation and the number of ISCs is more prominent if the duration of breast feeding is short, which further agrees with the experimental data showing that maternal IgA prevents stimulation of the mucosal immune system.36
The timing of colonisation with B fragiliswas further shown to be important for the development of IgA-secreting and IgM-secreting cells. The highest number of IgA-secreting cells at 2 months of age and IgM-secreting cells at 6 months of age were found in infants colonised at 1–2 months of age, and the lowest number of ISCs was found in infants who were never colonised during the six month follow up period. This agrees with the work on mice, implying that the timing of the intestinal microbial stimulus is of utmost importance for the development of the mucosal immune system.9
The predominance of the IgM isotype lymphocyte response in association with intestinal microbial colonisation is in keeping with previous findings that young infants respond to mucosal stimuli with IgM class antibodies.12 ,22 The increased IgM response to mucosal stimuli is believed to compensate for the relative absence of IgA early in life.10 ,11 In addition, in a study on the expression of homing receptors of peripheral ISCs, the IgM-secreting cells were shown to have more homing tendencies towards the mucosae than IgA and IgG isotypes, and an isotype switch from IgM to IgA was suggested to take place only after homing to gut mucosa.37
It has previously been established that assessment of circulating peripheral blood lymphocytes is a sensitive and specific method for measuring humoral immune responses at mucosal surfaces.38 ,39 A large proportion of peripheral IgA-secreting cells produce polymeric IgA with subclass distribution characteristic of external secretions when stimulated with pokeweed mitogen in vitro.40 Therefore most peripheral IgA-secreting cells have been suggested to be precursors of IgA plasma cells with the potential to populate mucosal tissues.2 ,40Further support for this notion comes from studies on mice showing that 90% of all ICSs come from the small intestine, Peyer's patches, or mesenteric lymph nodes, and that nearly all the IgA-secreting cells are found in the small intestine.41 ,42 The increased number of circulating IgA-secreting and IgM-secreting cells found in this study may thus also reflect improved mucosal protection against antigens met by the intestinal surfaces.
Our results suggest that there is a connection between the method of delivery and maturation of the humoral immune system for the following reasons. A delay in intestinal colonisation with B fragilis is the most permanent difference in neonates delivered by caesarean section compared with vaginally delivered infants.13 ,14 ,43 We recently established that rates of colonisation by B fragilis andBifidobacterium-like andLactobacillus-like bacteria were significantly lower during the first few months of life in infants born by caesarean section than in naturally born infants.19 The most consistent difference in the colonisation rates between the two groups was seen in that of B fragilis. None of the infants delivered by caesarean section had permanent colonisation with B fragilis before 2 months of age whereas 52–79% of the vaginally delivered infants were colonised with these bacteria during that period. At 6 months of age, the colonisation rate for B fragilis in the infants delivered by caesarean section was still only half (36%) of that in the vaginally delivered infants (76%).19 Thus the important immunostimulating effect of Bacteroidessp is lacking in these infants during a critical period of immunological maturation.
Our observations add an interesting facet to the discussion on the possible protective role of microbial contacts in the prevention of allergic diseases.44-46 This protective effect has been explained by the microbes' ability to change the T helper cell balance from the neonatally predominating T helper 2 phenotype, which instructs uncommitted B lymphocytes to produce IgE through release of interleukin 4, to the T helper 1 phenotype during a critical period in infancy before the immunological memory has developed.27 ,47 The exact timing of the T helper cell polarisation is not known, but early infancy is the most logical time.48 The factors that divert this process are not known, but animal studies suggest that one could be the indigenous bacterial flora.9 Furthermore, we now show that microbes of the normal flora stimulate maturation of IgA-secreting cells, the first line immune protection against foreign antigens at the mucosal membranes.49 It may therefore be no coincidence that the incidence of allergic diseases are increasing in parallel with the rate of sterile caesarean sections.
We thank Tuija Poussa, MSc, for statistical help, research nurse Satu Ekblad, for help with the clinical work, Mrs Tuija Turjas and Mrs Etta-Liisa Väänänen, for performing the ELISPOT assays, and Mr Erkki Nieminen, MSc, for help in preparing the figures. This study was supported by the South-West Finnish Fund of Neonatal Research and the Finnish Cultural Foundation.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.